المصدر: A Randomized, Double-Blind, Placebo-Controlled, Multi-Regional Phase III Clinical Study of Toripalimab Alone or in Combination With Tifcemalimab (JS004/TAB004) as Consolidation Therapy in Patients With Limited-Stage Small Cell Lung Cancer Without Disease Progression Following Chemoradiotherapy

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT06095583Test

المساهمون: Xiaorong Dong, Director

المصدر: A Trial of SHR-1316 Maintenance Therapy for Limited Stage Small Cell Lung Cancer Without Progression After First Line Concurrent Chemoradiotherapy Treatment

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04647357Test